TickerGuard
Buy Day today: Good (67) Broad market participation · no major macro event

SOPHiA GENETICS SA (SOPH)

Healthcare Health Information Services
5.70 $
+0.4% vs. previous close
Closing price · As of: 3. Aug 2026

SOPHiA GENETICS SA (SOPH) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Revenue" came in at 22 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Income Statement SOPH
Tick rows to compare them in a chart (up to 4) Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 LTM
15 16 17 16 16 16 18 18 18 19 22 22 81
5.0 5.0 5.1 5.4 5.0 5.2 5.6 5.6 6.1 6.6 7.0 6.9 27
10 11 12 10 11 11 12 12 12 13 15 15 55
8.9 9.0 9.8 9.4 8.0 7.9 9.1 9.1 8.5 9.4 8.5 11 37
14 13 13 13 11 11 13 12 12 14 22 14 62
30 28 31 29 26 26 30 28 31 31 33 32 126
-20 -17 -19 -19 -15 -15 -17 -16 -19 -18 -18 -17 -72
1.3 0.1 0.5 1.9 0.7 0.6 1.7 1.7 1.7 5.6
-21 -14 -24 -13 -15 -18 -15 -17 -22 -19 -20 -19 -80
0.1 0.3 0.0 0.3 0.2 0.1 0.6 0.5 0.8 0.6 -0.4 0.3 1.3
-21 -14 -24 -14 -15 -18 -15 -17 -22 -20 -19 -19 -81
-18 -11 -20 -11 -12 -16 -7.9 -14 -19 -17 -15 -15 -66

LTM = last twelve months (sum of the four most recent quarters).

Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?